At the midpoint of the Measles & Rubella Strategic Framework (MRSF) 2021–2030, this Midterm Review assesses global progress toward measles and rubella elimination and identifies the course corrections needed to achieve 2030 targets. While notable progress has been made, the world remains off-track to reach elimination targets. Persistent immunity gaps, rising outbreaks, inequities in access, and a tightening global health financing landscape are undermining progress. The findings below summarize the state of measles and rubella from 2021–2024 and set the stage for strategic recommendations for 2026–2030.

Langues

  • Anglais

Année de publication

2026

Type

Rapport

Catégories

  • Initiatives mondiales

Maladies

  • Rougeole
  • Rubéole

Organisations

  • La Foundation Bill et Melinda Gates
  • Gavi, l'Alliance du vaccin
  • UNICEF
  • Centres de prévention et de contrôle des maladies (CDC)
  • Organisation Mondiale de la Santé (OMS)

Ajouté par: Géraldine Nemrod

Ajouté le: 2026-03-09 12:38:55

Consultations: 779